The DOI matches its Crossref record; the references it cites are not checked yet; 24 of the 69 sources its claims cite were checked for support.
Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS)
Open accessAbstract
Purpose of Review: The polycystic ovary syndrome (PCOS) is an endocrine dysfunction associated with a myriad of metabolic disorders and high rate of infertility. In order to aid its management, several lifestyle/dietary interventions have been evaluated. Very low-calorie ketogenic diet (VLCKD) is rapidly showing promising benefits not only in obesity but also in the treatment of other metabolic diseases. The main objective of this review is to assess the scientific evidence in support of this dietary pattern as an effective measure for treating PCOS and the metabolic disorders associated with it. Recent Findings: Preliminary data suggested significant improvements in body weight and composition, metabolic profile (glucose, serum insulin, triglycerides, total and low-density lipoprotein cholesterol), and insulin resistance following VLCKD. However, the evidence is still scarce and needs to be more substantiated. Summary: Weight reduction in women with PCOS has been shown to improve metabolic derangements and body composition, but there is no consensus on the ideal dietary pattern or macronutrient composition. There is some evidence supporting the possible role of the Mediterranean diet in improving infertility (along with other well-known metabolic benefits) in women with PCOS. Of note, VLCKD might be considered a potential intervention for the short-term treatment of PCOS, but it must be prescribed and carefully guided by professionals.
Overview
CoChat Summary
TL;DR
This narrative review assesses evidence for ketogenic diets, especially very low-calorie ketogenic diet (VLCKD), as a medical prescription in women with PCOS. It concludes that VLCKD may be effective for short-term treatment of PCOS and associated metabolic disorders, but evidence remains scarce and the diet must be professionally prescribed and supervised.
Key findings
- Preliminary data suggest VLCKD improves body weight and composition, metabolic profile (glucose, serum insulin, triglycerides, total and LDL cholesterol), and insulin resistance in PCOS, but the evidence is still scarce and needs to be more substantiated.
- In the Paoli et al. trial of 14 overweight women with PCOS on a 12-week KEMEPHY protocol, average weight loss was 9.43 kg (81.19 ± 8.44 kg to 71.76 ± 6.66 kg; p < 0.001), BMI decreased by 3.35 (28.84 ± 2.10 to 25.49 ± 1.69 kg/m²; p < 0.001), and glucose, insulin, HOMA-IR, triglycerides, total cholesterol, and LDL cholesterol significantly decreased.
- A retrospective study of 25 women with obesity and PCOS undergoing VLCKD for 12 weeks showed significant decreases in anti-Müllerian hormone and significant increases in progesterone and SHBG, suggesting possible benefit for ovarian reserve and luteal function.
- Other dietary patterns have evidence in PCOS: a meta-analysis of 19 clinical trials (1193 patients) found restricted diets significantly improved insulin resistance, fasting glucose, and body composition; a meta-analysis of 8 studies (412 women with PCOS and overweight/obesity) found low-glycemic-index diets improved clinical and biochemical features.
Methods
- Narrative review; the authors state the main objective is to assess scientific evidence supporting VLCKD as an effective measure for treating PCOS and its associated metabolic disorders.
- The paper synthesizes prior literature, including clinical trials, meta-analyses, and reviews, with cited PCOS-specific studies such as 14 overweight women on KEMEPHY for 12 weeks, 25 women with obesity and PCOS on VLCKD for 12 weeks, and 9 women with PCOS and obesity on a high-protein very low-calorie diet for 4 weeks.
- No systematic search strategy, inclusion criteria, or formal meta-analysis is reported in the text.
Limitations
- The authors state that evidence is still scarce and needs to be more substantiated; there is no consensus on the ideal dietary pattern or macronutrient composition for PCOS.
- The authors state that long-term VLCKD interventions for PCOS have not been published, and VLCKD has contraindications and side effects, so it should be limited to specific patients and prescribed under professional supervision.
- Evident from the text: this is a narrative review without a reported systematic search or formal quality assessment, and many cited PCOS-specific ketogenic studies are small and short-term (e.g., 14 women for 12 weeks; 25 women for 12 weeks; 9 women for 4 weeks), limiting generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
21 Valid · 1 Not valid · 37 Not checked · 6 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, it should be highlighted that there is still no consensus on the best dietary pattern to follow in order to effectively lose weight in women with PCOS [11].”
§ Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) > Introduction
What the sources say
- Supportedcites [11] Barrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C, et al. Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS). Nutrients. 2019;11(10). source
The Introduction (p. 1) states verbatim in substance: 'However, it is still debated what is the best effective nutritional pattern that should be followed to lose weight in PCOS,' immediately after noting weight management as a main treatment strategy per the International Evidence-based Guideline. The same paragraph adds that 'no evidence is available' regarding the Mediterranean diet's effects in PCOS, reinforcing the absence of consensus. The Discussion (p. 4) likewise frames MD as only 'conceivable' as 'one of the best nutritional strategies' for PCOS, not established. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Moreover, in women with PCOS and obesity, significant alterations in carbohydrate, lipid, and amino acid metabolism with specific metabolomic signatures have been identified (e.g., decrease in citric and lactic acid levels, lysophosphatidylcholines, and glycerolphosphocholine and increase in free fatty acids (carnitine, adipic acid, linoleic acid, oleic acid) etc.) [14].”
§ Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) > Nutritional Approach to PCOS
What the sources say
- Supportedcites [14] Vonica CL, Farcas AD, Roman G, Mureșan AA, Fodor A, Cernea S, et al. Metabolomic biomarkers of polycystic ovary syndrome related-obesity: a review of the literature. Revista Română de Medicină de Laborator. 2020;28:241–56. source
The Abstract (Results section) of our copy states the parenthetical detail almost verbatim: the lipid signature in obese women with PCOS showed increased free fatty acids (carnitine, adipic acid, linoleic acid, oleic acid) and lower lysophosphatidylcholines and glycerolphosphocholine, and 'a decrease in citric and lactic acid levels characterized obese PCOS women'. The Conclusions (p. last) state 'compelling evidence of significant alterations in carbohydrate, lipid, and amino acid metabolism among women with obesity-associated PCOS', and Sections 1–4 plus Table 2 supply the carbohydrate, lipid and amino-acid metabolomic signatures. The only caveat is the same Conclusions sentence that no single typical metabolomic profile or biomarker predicts PCOS, which does not contradict the identification of pathway-specific signatures. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Reducing 5 to 10% of the usual weight can improve reproductive function [15].”
§ Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) > Nutritional Approach to PCOS
What the sources say
- Supportedcites [15] Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and Over. Curr Obes Rep. 2017;6(2):187–94. source
The section on PCOS and infertility in women states that weight loss improves ovulatory cycles and pregnancy outcomes in women with PCOS, with more robust evidence at 5% and 10% total body weight loss. This supports the claimed improvement in reproductive function. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The authors concluded that there is preliminary evidence to support the role of the MD diet in the management of PCOS, to reduce inflammatory status, IR, and hyperandrogenemia [11].”
§ Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) > Nutritional Approach to PCOS > Mediterranean Diet
What the sources say
- Supportedcites [11] Barrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C, et al. Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS). Nutrients. 2019;11(10). source
The Conclusions section of our copy states almost exactly what is attributed: 'These data could support a therapeutic role of single foods and nutrients of the Mediterranean dietary pattern in the PCOS, by contributing to reduce the inflammatory status that paves the way for IR and hyperandrogenemia.' The citing paraphrase's hedge 'preliminary evidence' matches the source's own 'could support', and the population (women with PCOS) and the three targets (inflammatory status, IR, hyperandrogenemia) are all those of the source; the Discussion (oleocanthal/EVOO passage) reinforces the anti-inflammatory-to-insulin-sensitivity rationale. Only minor flattening: the source presents IR and hyperandrogenemia as downstream of the inflammation that MD adherence would reduce, rather than as independently measured effects. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“(d) the side effects were mild and transient.”
§ Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) > PCOS and VLCKD
What the sources say
- Supportedcites [47] Muscogiuri G, El Ghoch M, Colao A, Hassapidou M, Yumuk V, Busetto L, et al. European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis. Obes Facts. 2021;14(2):222–45. source
The Discussion (p. 22) states that the included studies 'found no meaningful common side effects' and that these 'are reported to be clinically mild and often recovery occurs spontaneously', and the Abstract (p. 1) concludes VLCKD 'can be considered a safe nutritional approach under a health professional's supervision since the most common side effects are usually clinically mild and easily to manage and recovery is often spontaneous'. The transient/self-limiting character is reflected elsewhere too (Lipid Profile Changes, p. 21: the LDL rise 'is transient and values usually return to normal levels'; Common Side Effects, p. 20: natriuresis and kaliuresis resolve spontaneously within days). The source hedges with 'most common' and 'usually/often', whereas the citing list item states it flatly, but the substance attributed to this source is what our copy says. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
17 more claims · 8 with their cited sources checked
Create a free account to see all 65 claims and to verify the 45 references still open.
- It may state two separate claims as one. 37
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Weight loss and lifestyle changes have proven to be effective in restoring menstrual regularity and reproductive function, improving hyperandrogenism, glucose and lipid metabolism, and insulin sensitivity, thus reducing cardiovascular risk in women with PCOS [18–20].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) > Introduction
“Ninety percent of the calories in this diet come from fats, and the remaining 10% are from carbohydrates and proteins.”
§ Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) > PCOS and VLCKD
“the first active step of VLCKD, which is characterized by a very low-calorie intake (650–800 kcal/day), low in carbohydrates (< 30 g daily from vegetables), and lipids (only 20 g per day, derived also from olive oil).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) > PCOS and VLCKD
“Glucose decreased from 5.10 ± 0.25 mmol/L to 4.64 ± 0.24 mmol/L (p < 0.001), serum insulin from 12.62 ± 0.48 μU/mL to 11.31 ± 0.60 μU/mL (p < 0.001), and consequently HOMA-IR from 2.85 ± 0.15 to 2.32 ± 0.13 (p < 0.001) [17].”
§ Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) > References
“17. Farshchi H Rane A Love A Kennedy RL Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management J Obstet Gynaecol 2007 27 8 762 773 10.1080/01443610701667338 18097891”
Citations
The citation lists are queued
They are fetched later and appear here then.
References 48 · Cited by 62
Metadata
- Authors
- Barrea, L., Verde, L., Camajani, E., Cernea, S., Frias-Toral, E., Lamabadusuriya, D., Ceriani, F., Savastano, S., Colao, A., & Muscogiuri, G.
- Affiliations
- Pegaso University (IT)
- University of Naples Federico II (IT)
- Sapienza University of Rome (IT)
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO)
- General Sir John Kotelawala Defence University (LK)
- Universidad de la República de Uruguay (UY)
- Federico II University Hospital (IT)
- Corresponding author
- Muscogiuri, Giovanna
- ORCID
- Venue
- Current Nutrition Reports
- Published
- 2023-01-25
- Volume
- 12
- Issue
- 1
- Pages
- 56-64
- ISSN
- 2161-3311 (ISSN-L)
- PMC
- PMC9974679
- OpenAlex
- W4318025967
- Cited by
- 62
- References
- 48
- Citations by year
- 2026: 17 · 2025: 18 · 2024: 16 · 2023: 11
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Update notices
- correction (2023-02-16)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Current Nutrition Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Greater South Information System
- Funders
- Università degli Studi di Napoli Federico II
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- polycystic ovary syndrome, ketogenic diet, very low-calorie ketogenic diet, insulin resistance, weight loss, body composition, metabolic disorders, infertility, Mediterranean diet, macronutrient composition
- MeSH terms
- Female, Humans, Infertility, Metabolic Diseases, Polycystic Ovary Syndrome, Diet, Mediterranean, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS). https://app.cochat.ai/papers/10.1007/s13668-023-00456-1
- The paper
- Barrea, L., Verde, L., Camajani, E., Cernea, S., Frias-Toral, E., Lamabadusuriya, D., Ceriani, F., Savastano, S., Colao, A., & Muscogiuri, G. (2023). Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS). Current Nutrition Reports. https://doi.org/10.1007/s13668-023-00456-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
